Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-25-335678 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 22, 2025 |
| Document | View SEC Filing |
Transactions
6
Total Shares
6,286
Total Value
$31,350.34
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Dec 22, 2025 | Exercise/Conversion | 2,825 | $9.86 | $27,854.50 | 78,527 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Dec 22, 2025 | Exercise/Conversion | 219 | $9.86 | $2,159.34 | 78,746 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Dec 22, 2025 | Exercise/Conversion | 99 | $13.50 | $1,336.50 | 78,845 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Dec 22, 2025 | Exercise/Conversion | 2,825 | $0.00 | $0.00 | 3,550 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Dec 22, 2025 | Exercise/Conversion | 219 | $0.00 | $0.00 | 2,628 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Dec 22, 2025 | Exercise/Conversion | 99 | $0.00 | $0.00 | 29,905 | Direct | โ | View Details |